Several notable collaborative initiatives have made significant strides in the fight against cancer. The Cancer Genome Atlas (TCGA) is an excellent example, involving multiple research institutions to catalog genetic mutations responsible for cancer. Another is the International Cancer Genome Consortium (ICGC), which aims to generate comprehensive descriptions of genomic, transcriptomic, and epigenomic changes in various cancer types. These initiatives have already led to the identification of many potential targets for new cancer treatments.
